|
Piramal Pharma Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
26896.01 Cr.
|
P/BV
|
3.40
|
Book Value (Rs.)
|
59.53
|
|
52 Week High/Low (Rs.)
|
308/182
|
FV/ML
|
10/1
|
P/E(X)
|
295.39
|
|
Bookclosure
|
16/07/2025
|
EPS (Rs.)
|
0.69
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 4958.29 | 4192.89 | 4510.93 | 3660.23 | 3879.55 |
| Total Income From Operations | 4958.29 | 4192.89 | 4510.93 | 3660.23 | 3879.55 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1009.12 | 1046.62 | 1027.71 | 949.12 | 836.76 |
| Purchase of Traded Goods | 707.78 | 709.54 | 663.99 | 511.78 | 534.20 |
| Increase/Decrease in Stocks | 43.91 | -285.32 | -2.16 | -196.44 | 94.07 |
| Employees Cost | 1168.25 | 1139.22 | 1017.93 | 1011.57 | 965.76 |
| Depreciation | 439.57 | 376.77 | 382.45 | 358.12 | 348.84 |
| Other Expenses | 1130.50 | 1036.73 | 1005.16 | 986.24 | 1010.16 |
| Total Expenses | 4499.13 | 4023.56 | 4095.08 | 3620.39 | 3789.79 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 459.16 | 169.33 | 415.85 | 39.84 | 89.76 |
| Other Income | 54.16 | 80.65 | 87.89 | 87.50 | 107.04 |
| P/L Before Interest, Excpt. Items & Tax | 513.32 | 249.98 | 503.74 | 127.34 | 196.80 |
| Interest | 206.99 | 214.60 | 220.10 | 228.39 | 198.90 |
| P/L Before Exceptional Items & Tax | 306.33 | 35.38 | 283.64 | -101.05 | -2.10 |
| Exceptional Items | 0.00 | 0.00 | -62.79 | 0.00 | 0.00 |
| P/L Before Tax | 306.33 | 35.38 | 220.85 | -101.05 | -2.10 |
| Tax | 182.42 | 141.09 | 135.46 | 26.01 | 61.32 |
| P/L After Tax from Ordinary Activities | 123.91 | -105.71 | 85.39 | -127.06 | -63.42 |
| Net Profit/Loss For the Period | 123.91 | -105.71 | 85.39 | -127.06 | -63.42 |
| Share Of P/L Of Associates | 33.27 | 39.66 | 25.99 | 33.50 | 23.35 |
| Net P/L After Minority Interest & Share Of Associates | 157.18 | -66.05 | 111.38 | -93.56 | -40.07 |
| | | | | | |
| Equity Share Capital | 1324.34 | 1323.14 | 1322.95 | 1322.95 | 1193.32 |
| Reserves And Surplus | 0.00 | 0.00 | 6588.42 | 0.00 | 0.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.93 | -0.50 | 0.64 | -0.75 | -0.53 |
| Diluted EPS (Rs.) | 0.94 | -0.50 | 0.65 | -0.75 | (0.53) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.93 | -0.50 | 0.64 | -0.75 | -0.53 |
| Diluted EPS (Rs.) | 1.19 | -0.50 | 0.84 | -0.75 | (0.34) |
| | | | | | |
| PBITOE Margin (%) | 9.26 | 4.03 | 9.21 | 1.08 | 2.31 |
| PBTE Margin (%) | 6.17 | 0.84 | 6.28 | -2.76 | -0.05 |
| PBT Margin (%) | 6.17 | 0.84 | 4.89 | -2.76 | -0.05 |
| PAT Margin (%) | 2.49 | -2.52 | 1.89 | -3.47 | -1.63 |
| PAT After MI And SOA Margin (%) | 3.17 | -1.57 | 2.46 | -2.55 | -1.03 |
